The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Greg Belinfanti

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Greg Belinfanti is a private equity based in New York across 125 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Greg Belinfanti on Healthcare.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Greg Belinfanti — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Greg Belinfanti — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Greg Belinfanti — 125
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Greg Belinfanti — Healthcare

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Greg Belinfanti — Private Equity · NEW YORK · 125 tracked deals · Greg Belinfanti portfolio

Similar investors

• Opto Custom GP 2023 LLC
• Harsha Marti
• Jin Hing Chin
• Elodie Dupuy
• Steven Leischner
• Fady Abdel-Nour
• Timothy Huang
• Antler Special Opportunities GP II LLC
• iCapital Strategies LLC
• Edward Tsai

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Greg Belinfanti · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory